当前位置:首页 > 股票大全 > 华北制药 600812 财务分析

华北制药财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

华北制药(600812)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入2,557,512,113.0410,120,201,384.847,974,681,092.85,233,404,242.63
营业总成本2,492,470,540.3810,043,246,697.977,859,360,976.385,158,617,183.57
营业利润57,678,495.87156,453,221.39120,992,425.0482,518,686.67
利润总额58,024,653.96158,535,685.79127,084,369.4887,297,997.87
净利润32,794,050.3149,387,877.2250,382,686.4242,803,558.02
其他综合收益38,463.8-2,004,968.681,609,162.751,696,264.67
综合收益总额32,832,514.1147,382,908.5451,991,849.1744,499,822.69
华北制药(600812)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计7,907,776,684.898,017,591,063.589,084,512,483.518,948,204,316.52
非流动资产合计12,968,018,139.3612,939,109,004.2112,424,449,282.1812,165,562,988.77
资产总计20,875,794,824.2520,956,700,067.7921,508,961,765.6921,113,767,305.29
流动负债合计9,793,780,408.0310,268,565,136.6411,051,380,529.7511,017,794,761.94
非流动负债合计4,778,200,572.654,417,724,752.064,194,216,515.023,840,478,967.77
负债合计14,571,980,980.6814,686,289,888.715,245,597,044.7714,858,273,729.71
归属于母公司股东权益合计5,334,065,618.345,315,303,557.085,330,346,036.195,328,626,505.69
股东权益合计6,303,813,843.576,270,410,179.096,263,364,720.926,255,493,575.58
负债和股东权益合计20,875,794,824.2520,956,700,067.7921,508,961,765.6921,113,767,305.29
华北制药(600812)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计2,273,257,626.868,756,740,371.066,642,956,178.564,208,784,646.04
经营活动现金流出小计1,706,174,847.997,732,473,715.946,049,231,151.023,943,799,545.67
经营活动产生的现金流量净额567,082,778.871,024,266,655.12593,725,027.54264,985,100.37
投资活动现金流入小计-1,280,419.691,280,419.69373,400
投资活动现金流出小计192,682,233.74883,035,146.08430,130,233.54257,476,251.86
投资活动产生的现金流量净额-192,682,233.74-881,754,726.39-428,849,813.85-257,102,851.86
筹资活动现金流入小计2,022,450,00010,783,849,198.638,215,709,448.635,503,252,576.51
筹资活动现金流出小计2,511,842,313.111,487,992,510.588,520,941,767.915,570,407,396.28
筹资活动产生的现金流量净额-489,392,313.1-704,143,311.95-305,232,319.28-67,154,819.77
汇率变动对现金及现金等价物的影响2,477,280.4312,067,905.59,176,198.467,511,289.22
现金及现金等价物净增加额-112,514,487.54-549,563,477.72-131,180,907.13-51,761,282.04
期末现金及现金等价物余额392,490,089.02505,004,576.56923,387,147.151,002,806,772.24
华北制药600812相关数据
今日股市大盘指数